Cargando…
Cancer Genomics
Modern cancer genomics has emerged from the combination of the Human Genome Reference, massively parallel sequencing, and the comparison of tumor to normal DNA sequences, revealing novel insights into the cancer genome and its amazing diversity. Recent developments in applying our knowledge of cance...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752025/ https://www.ncbi.nlm.nih.gov/pubmed/26937274 http://dx.doi.org/10.12688/f1000research.6645.1 |
| _version_ | 1782415664067117056 |
|---|---|
| author | Mardis, Elaine |
| author_facet | Mardis, Elaine |
| author_sort | Mardis, Elaine |
| collection | PubMed |
| description | Modern cancer genomics has emerged from the combination of the Human Genome Reference, massively parallel sequencing, and the comparison of tumor to normal DNA sequences, revealing novel insights into the cancer genome and its amazing diversity. Recent developments in applying our knowledge of cancer genomics have focused on the utility of these data for clinical applications. The emergent results of this translation into the clinical setting already are changing the clinical care and monitoring of cancer patients. |
| format | Online Article Text |
| id | pubmed-4752025 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | F1000Research |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47520252016-03-01 Cancer Genomics Mardis, Elaine F1000Res Review Modern cancer genomics has emerged from the combination of the Human Genome Reference, massively parallel sequencing, and the comparison of tumor to normal DNA sequences, revealing novel insights into the cancer genome and its amazing diversity. Recent developments in applying our knowledge of cancer genomics have focused on the utility of these data for clinical applications. The emergent results of this translation into the clinical setting already are changing the clinical care and monitoring of cancer patients. F1000Research 2015-10-28 /pmc/articles/PMC4752025/ /pubmed/26937274 http://dx.doi.org/10.12688/f1000research.6645.1 Text en Copyright: © 2015 Mardis E http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Review Mardis, Elaine Cancer Genomics |
| title | Cancer Genomics |
| title_full | Cancer Genomics |
| title_fullStr | Cancer Genomics |
| title_full_unstemmed | Cancer Genomics |
| title_short | Cancer Genomics |
| title_sort | cancer genomics |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752025/ https://www.ncbi.nlm.nih.gov/pubmed/26937274 http://dx.doi.org/10.12688/f1000research.6645.1 |
| work_keys_str_mv | AT mardiselaine cancergenomics |